We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+9.08%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$32.9B
AUM Growth
+$5.06B
Cap. Flow
+$2.8B
Cap. Flow %
8.52%
Top 10 Hldgs %
5.63%
Holding
3,405
New
347
Increased
1,675
Reduced
1,120
Closed
228

Sector Composition

Rank Sector Weight
1 Financials 11.55%
2 Industrials 10.81%
3 Technology 10.42%
4 Consumer Discretionary 9.8%
5 Healthcare 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
URS
26
DELISTED
URS CORP
URS
$91.8M 0.28%
1,732,876
+15,240
+0.9% +$802K
AMGN icon
27
Amgen
AMGN
$211B
$89.5M 0.27%
783,822
-93,657
-11% -$10.7M
CMCSA icon
28
Comcast
CMCSA
$87.4B
$88.9M 0.27%
3,422,380
+134,788
+4% +$3.25M
BA icon
29
Boeing
BA
$167B
$88.6M 0.27%
649,372
+97,458
+18% +$12.7M
LMT icon
30
Lockheed Martin
LMT
$133B
$87.6M 0.27%
589,355
+11,580
+2% +$1.57M
MO icon
31
Altria Group
MO
$126B
$86.4M 0.26%
2,250,776
+390,419
+21% +$14.4M
AFG icon
32
American Financial Group
AFG
$12.1B
$85.6M 0.26%
1,483,328
+26,833
+2% +$1.5M
WFC icon
33
Wells Fargo
WFC
$257B
$85.4M 0.26%
1,881,703
+142,247
+8% +$6.14M
JPM icon
34
JPMorgan Chase
JPM
$926B
$83.7M 0.25%
1,431,598
+83,876
+6% +$4.6M
SLB icon
35
SLB Ltd
SLB
$73.3B
$83.5M 0.25%
926,274
+498,317
+116% +$45M
BSJF
36
DELISTED
GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF
BSJF
$83.3M 0.25%
3,109,036
+1,101,014
+55% +$29.6M
PSX icon
37
Phillips 66
PSX
$83.9B
$82.3M 0.25%
1,066,739
+234,160
+28% +$15.6M
HBAN icon
38
Huntington Bancshares
HBAN
$34.3B
$80.4M 0.24%
8,328,297
+1,447,381
+21% +$13M
MDY icon
39
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.5B
$80M 0.24%
327,495
+250,700
+326% +$59M
WRB icon
40
W.R. Berkley
WRB
$28.3B
$79.5M 0.24%
6,183,749
+121,189
+2% +$1.56M
IBM icon
41
IBM
IBM
$213B
$79.4M 0.24%
442,988
+75,896
+21% +$13.1M
ABBV icon
42
AbbVie
ABBV
$472B
$78.9M 0.24%
1,494,127
+107,838
+8% +$5.3M
PFE icon
43
Pfizer
PFE
$144B
$78.4M 0.24%
2,697,400
+204,104
+8% +$5.94M
CTSH icon
44
Cognizant
CTSH
$26.5B
$78M 0.24%
1,545,246
+807,268
+109% +$36.8M
META icon
45
Meta Platforms (Facebook)
META
$1.49T
$77.9M 0.24%
1,425,716
+447,164
+46% +$22.5M
BIIB icon
46
Biogen
BIIB
$31.5B
$77.3M 0.23%
276,244
+17,535
+7% +$4.54M
JNJ icon
47
Johnson & Johnson
JNJ
$647B
$77.1M 0.23%
841,881
-13,670
-2% -$1.26M
NCI
48
DELISTED
Navigant Consulting, Inc.
NCI
$76.6M 0.23%
3,989,687
-71,647
-2% -$1.27M
HRL icon
49
Hormel Foods
HRL
$14.3B
$76.3M 0.23%
3,380,222
-342,882
-9% -$7.51M
PG icon
50
Procter & Gamble
PG
$337B
$75.7M 0.23%
929,527
+108,516
+13% +$8.84M

Similar funds

Guggenheim Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Guggenheim Capital held 3,405 positions worth $32.9B, up 18% from $27.9B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

Guggenheim Capital deployed $2.8B of net new capital in Q4 2013, opening 347 new positions and adding to 1,675 existing holdings. Its largest new stake was Houghton Mifflin Harcourt Company: 3,489,206 shares worth $57.6M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $112M trimmed.

  • Guggenheim Capital's largest Q4 2013 buy was Houghton Mifflin Harcourt Company: 3,489,206 shares worth $57.6M.
  • Guggenheim Capital added most to iShares Russell 2000 ETF in Q4 2013, an estimated $67M increase.
  • Guggenheim Capital's biggest Q4 2013 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $112M.
  • Guggenheim Capital fully exited State Street SPDR Dow Jones Industrial Average ETF Trust in Q4 2013, selling an estimated $122M.
  • Guggenheim Capital's ten largest holdings make up 5.6% of its $32.9B portfolio in Q4 2013.
  • Guggenheim Capital opened 347 new positions and closed 228 in Q4 2013.
  • Guggenheim Capital's portfolio value rose 18% quarter-over-quarter to $32.9B.

Based on Guggenheim Capital's 13F filing for Q4 2013, filed 14 Feb 2014.